Compare Nuwellis Inc (NUWE) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Vanguard Emerging Markets Stock Index Fund ETF trades at $58.85. The key difference: Vanguard Emerging Markets Stock Index Fund ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | VWO | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | — |
52-Week High | $527.46 | $61.24 |
52-Week Low | $2.80 | $49.54 |
Enterprise Value | -$722.58K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
VWO trades at $57.93, up 0.16% today, with a bearish technical signal from moving averages and oscillators showing neutral readings. The ETF's low expense ratio of 0.06% and a 2.4% dividend yield are key attractions, though financial ratios are unavailable. Recent news highlights emerging markets' record inflows and comparisons with competing funds, emphasizing cost advantages and exposure to developing economies.
Outlook is mixed: strong institutional interest and low costs support long-term growth in emerging markets, but bearish technicals and geopolitical risks in regions like China pose headwinds. Investors should weigh the ETF's diversification benefits against volatility from economic uncertainties and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
